581 related articles for article (PubMed ID: 16406828)
41. Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role.
Aubert J; Begriche K; Knockaert L; Robin MA; Fromenty B
Clin Res Hepatol Gastroenterol; 2011 Oct; 35(10):630-7. PubMed ID: 21664213
[TBL] [Abstract][Full Text] [Related]
42. 9-PAHSA Prevents Mitochondrial Dysfunction and Increases the Viability of Steatotic Hepatocytes.
Schultz Moreira AR; Rüschenbaum S; Schefczyk S; Hendgen-Cotta U; Rassaf T; Broering R; Hardtke-Wolenski M; Buitrago-Molina LE
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167328
[TBL] [Abstract][Full Text] [Related]
43. Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice.
Tomita K; Oike Y; Teratani T; Taguchi T; Noguchi M; Suzuki T; Mizutani A; Yokoyama H; Irie R; Sumimoto H; Takayanagi A; Miyashita K; Akao M; Tabata M; Tamiya G; Ohkura T; Hibi T
Hepatology; 2008 Aug; 48(2):458-73. PubMed ID: 18666257
[TBL] [Abstract][Full Text] [Related]
44. Hepatic microcirculation in fatty liver disease.
Farrell GC; Teoh NC; McCuskey RS
Anat Rec (Hoboken); 2008 Jun; 291(6):684-92. PubMed ID: 18484615
[TBL] [Abstract][Full Text] [Related]
45. Lipoic acid administration prevents nonalcoholic steatosis linked to long-term high-fat feeding by modulating mitochondrial function.
Valdecantos MP; Pérez-Matute P; González-Muniesa P; Prieto-Hontoria PL; Moreno-Aliaga MJ; Martínez JA
J Nutr Biochem; 2012 Dec; 23(12):1676-84. PubMed ID: 22464149
[TBL] [Abstract][Full Text] [Related]
46. Central role of mitochondria in drug-induced liver injury.
Pessayre D; Fromenty B; Berson A; Robin MA; Lettéron P; Moreau R; Mansouri A
Drug Metab Rev; 2012 Feb; 44(1):34-87. PubMed ID: 21892896
[TBL] [Abstract][Full Text] [Related]
47. Genipin ameliorates age-related insulin resistance through inhibiting hepatic oxidative stress and mitochondrial dysfunction.
Guan L; Feng H; Gong D; Zhao X; Cai L; Wu Q; Yuan B; Yang M; Zhao J; Zou Y
Exp Gerontol; 2013 Dec; 48(12):1387-94. PubMed ID: 24041487
[TBL] [Abstract][Full Text] [Related]
48. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder.
Hu J; Wang H; Li X; Liu Y; Mi Y; Kong H; Xi D; Yan W; Luo X; Ning Q; Wang X
Theranostics; 2020; 10(21):9702-9720. PubMed ID: 32863955
[No Abstract] [Full Text] [Related]
49. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.
Schuppan D; Schattenberg JM
J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():68-76. PubMed ID: 23855299
[TBL] [Abstract][Full Text] [Related]
50. Mitochondrial glutathione: hepatocellular survival-death switch.
Garcia-Ruiz C; Fernandez-Checa JC
J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S3-6. PubMed ID: 16958667
[TBL] [Abstract][Full Text] [Related]
51. A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model.
Sangineto M; Bukke VN; Bellanti F; Tamborra R; Moola A; Duda L; Villani R; Romano AD; Serviddio G
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33671262
[TBL] [Abstract][Full Text] [Related]
52. Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet.
Matsuzawa N; Takamura T; Kurita S; Misu H; Ota T; Ando H; Yokoyama M; Honda M; Zen Y; Nakanuma Y; Miyamoto K; Kaneko S
Hepatology; 2007 Nov; 46(5):1392-403. PubMed ID: 17929294
[TBL] [Abstract][Full Text] [Related]
53. Diallyl disulfide attenuates non‑alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, lipid peroxidation and inflammation in mice.
Zhang N; Wang Y; Zhang J; Liu B; Li G; Xin S; Xu K
Mol Med Rep; 2019 Aug; 20(2):1363-1372. PubMed ID: 31173200
[TBL] [Abstract][Full Text] [Related]
54. Nonalcoholic Steatohepatitis.
Suzuki A; Diehl AM
Annu Rev Med; 2017 Jan; 68():85-98. PubMed ID: 27732787
[TBL] [Abstract][Full Text] [Related]
55. GH-independent IGF-I action is essential to prevent the development of nonalcoholic steatohepatitis in a GH-deficient rat model.
Nishizawa H; Takahashi M; Fukuoka H; Iguchi G; Kitazawa R; Takahashi Y
Biochem Biophys Res Commun; 2012 Jun; 423(2):295-300. PubMed ID: 22659415
[TBL] [Abstract][Full Text] [Related]
56. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis.
Pérez-Carreras M; Del Hoyo P; Martín MA; Rubio JC; Martín A; Castellano G; Colina F; Arenas J; Solis-Herruzo JA
Hepatology; 2003 Oct; 38(4):999-1007. PubMed ID: 14512887
[TBL] [Abstract][Full Text] [Related]
57. Nonalcoholic fatty liver disease and mitochondrial dysfunction.
Wei Y; Rector RS; Thyfault JP; Ibdah JA
World J Gastroenterol; 2008 Jan; 14(2):193-9. PubMed ID: 18186554
[TBL] [Abstract][Full Text] [Related]
58. Impact of exenatide on mitochondrial lipid metabolism in mice with nonalcoholic steatohepatitis.
Kalavalapalli S; Bril F; Guingab J; Vergara A; Garrett TJ; Sunny NE; Cusi K
J Endocrinol; 2019 Jun; 241(3):293-305. PubMed ID: 31082799
[TBL] [Abstract][Full Text] [Related]
59. [Pathogenesis of primary nonalcoholic fatty liver disease].
Moreno Sánchez D
Med Clin (Barc); 2005 May; 124(17):668-77. PubMed ID: 15882516
[TBL] [Abstract][Full Text] [Related]
60. NEFA-induced ROS impaired insulin signalling through the JNK and p38MAPK pathways in non-alcoholic steatohepatitis.
Gao W; Du X; Lei L; Wang H; Zhang M; Wang Z; Li X; Liu G; Li X
J Cell Mol Med; 2018 Jul; 22(7):3408-3422. PubMed ID: 29602237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
